Q4 Earnings Estimates Look Quite Strong For These IBD 50 Names, Including Palantir
Q4 earnings season is still a few weeks away, with several IBD 50 firms, including Palantir stock, still in major growth mode.
Some parts of this page are not supported on your current browser version. Please upgrade to a recent browser version.
Q4 earnings season is still a few weeks away, with several IBD 50 firms, including Palantir stock, still in major growth mode.